首页
外语
计算机
考研
公务员
职业资格
财经
工程
司法
医学
专升本
自考
实用职业技能
登录
外语
Once-daily Pill Could Simplify HIV Treatment Bristol-Myers Squibb and Gilead Sciences have combined many HIV drugs into a si
Once-daily Pill Could Simplify HIV Treatment Bristol-Myers Squibb and Gilead Sciences have combined many HIV drugs into a si
admin
2011-01-05
56
问题
Once-daily Pill Could Simplify HIV Treatment
Bristol-Myers Squibb and Gilead Sciences have combined many HIV drugs into a single pill. Sometimes the best medicine is more than one kind of medicine. Malaria, tuberculosis and HIV/ AIDS, for example, are all treated with (51) of drugs. But that can mean a lot of pills to take. It would be (52) if drug companies combined all the medicines into a single pill, taken just once a day.
Now, two companies say they have done that for people just (53) treatment for HIV, the virus, that causes AIDS. The companies are Bristol-Myers Squibb and Gilead Sciences. They have (54) a single pill that combines three drugs currently on the market. Bristol-Myes Squibb sells one of them (55) the name of Sustiva. Gilead combined the (56) , Emtriva and Viread, into a single pill in two thousand four.
Combining drugs involves more than (57) issues. It also involves issues of competition (58) the drugs are made by different companies. The new once-daily pill is the result of (59) is described as the first joint venture agreement of its kind in the treatment of HIV.
In January the New England Journal of Medicine published a study of the new pill. Researchers compared its (60) to that of the widely used combination of Sustiva and Combivir. Combivir (61) two drugs, AZT and 3TC. The researchers say that after one year of treatment, the new pill suppressed HIV levels in more patients and with (62) side effects. Gilead paid for the study. Professor Joel Gallant at the Johns Hopkins School of Medicine in Baltimore, Maryland, led the research.
Glaxo Smith Kine reacted (63) the findings by saying that a single study is of limited value. It says the effectiveness of Combivir has been shown in each of more than fifty studies.
The price of the new once-daily pill has not been announced. But Gilead and Bristol-Myers Squibb say they will provide it at reduced cost to developing countries. They plan in the next few months to ask the United States Food and Drug Administration to (64) the new pill.
There are limits to who could take it because of the different drugs it contains. For example, (65) women are told not to take Sustiva because of the risk of birth disorders. Experts say more that forty million people around the world are living with HIV.
选项
A、one
B、ones
C、other
D、others
答案
D
解析
上面两家公司已经开发出将多种药合成为单片的新药,Bristol-Myers公司已合成了一种,Gilead公司则于2004年将其他两种Emtriva和Viread合成为单片,这里既然列出了这两种药的名称,所以就必须用others。
转载请注明原文地址:https://kaotiyun.com/show/jemd777K
本试题收录于:
职称英语卫生类A级题库职称英语分类
0
职称英语卫生类A级
职称英语
相关试题推荐
Youhearamantalkingtoagroupofpeoplewhoaregoingonanexpeditionintotherainforest.Whatdoesheadvisethemagai
Youmustanswerthisquestion.1.YourEnglishfriend,Bill,isatravelwriterandherecentlyvisitedatownwhichyouknowwe
Youaregoingtoreadanextractfromanovel.Forquestions7-13,choosetheanswer(A,B,CorD)whichyouthinkfitsbestac
AGOODSTARTTOAHOLIDAYIhadneverbeentoDenmarkbefore,sowhenIsetouttocatchtheferryinearlyMay,Ilittle【
BEARSThebearcanbeadangerousanimal,Theadultbearisverystronganditcankillaperson.Bearsaregoodat【C1】_____
MenTooMaySufferfromDomesticViolenceNearlythreein10menhaveexperiencedviolenceatthehandsofanintimatepartnerd
StomachUlcerStomachulcersarethecauseofseverepainformanypeople.Doctorshavebeenabletohelplessenthepainofulc
Manyuniversitycoursesarenotreallygearedtotheneedsofstudentsortheirfutureemployers.
PleasedonothesitatetocallmeifIcanbeoffurtherassistance,
随机试题
年度分类法是按照()和文件处理的年度,将档案分成若干类别。
通常所说的频谱是指()。
根据《专利法》的规定,下列各项中,不授予专利权的有()。
建筑工程施工质量验收的要求有()。
我国现行建筑安装工程费用项目组成中,环境保护费应计入()。
技术分析流派对待市场的态度是()。
以下事项属于公司层面的信息技术控制的有()。
香港特别行政区政治体制具有行政主导的特点,其表现有()(2016年法学综合课多选第26题)
A、 B、 C、 B
Justhavingabreakfromworkisnotenough,anewresearchsuggests.Itis【B1】______intheopenairthathavethestrongestres
最新回复
(
0
)